A consortium of twenty-seven states, augmented by the District of Columbia, has initiated legal proceedings against 23andMe, the prominent purveyor of direct-to-consumer genetic assays, seeking to enjoin the prospective divestiture of granular personal genetic information absent unequivocally explicit and informed consent from each implicated data subject, precipitated by a proposed acquisition by a biotechnology concern of the beleaguered genomic analysis enterprise; Oregon's Attorney General, Dan Rayfield, articulated in a press communiqué that the corpus of sensitive data – encompassing biological specimens, de-identified DNA sequences, hereditarily-linked phenotypic traits, and longitudinal medical dossiers – must not be commoditised without prior, affirmatively expressed, and fully cognisant authorisation from each individual.